458MO Efficacy of durvalumab (Durva) in combination with olaparib (Ola) and capivasertib (Cap) in patients (pts) with advanced or metastatic (met) cancers (Ca) (MEDIPAC)

458MO Efficacy of durvalumab (Durva) in combination with olaparib (Ola) and capivasertib (Cap) in patients (pts) with advanced or metastatic (met) cancers (Ca) (MEDIPAC)

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 33; p. S748
Main Authors: Lim, J., Raghav, S., Wong, A., Yong, W.P., Soo, R.A., Chee, C.E., Lee, S.C., Goh, B-C., Dent, R.A., Chan, J.J., Wong, K.Y.K., d/o Nathan Jeraj, S., Kwok, L., Schiavon, G., Foxley, A., Tan, D.S.
Format: Journal Article
Language:English
Published: 01-09-2022
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0923-7534
DOI:10.1016/j.annonc.2022.07.587